Skip to main content
TipRanks
Go Ultimate75% OFF

Zura Bio (94E) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Zura Bio has a market cap or net worth of EUR 108.35M. The enterprise value is EUR 343.63M.

Market Cap
EUR 108.35M
Enterprise Value
EUR 343.63M

Share Statistics

Zura Bio has 96,325,410 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
96,325,410
Owned by Insiders
8.13%
Owned by Institutions
18.32%

Financial Efficiency

Zura Bio’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -74.11%.

Return on Equity (ROE)
-0.68
Return on Assets (ROA)
-0.60
Return on Invested Capital (ROIC)
-74.11%
Return on Capital Employed (ROCE)
-0.74
Revenue Per Employee
0
Profits Per Employee
-1.72M
Employee Count
40
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Zura Bio is -1.11. Zura Bio’s PEG ratio is 0.02.

PE Ratio
-1.11
PS Ratio
0.00
PB Ratio
0.89
Price to FCF
-1.46
Price to Operating Cash Flow
-1.94
PEG Ratio
0.02

Income Statement

In the last 12 months, Zura Bio had revenue of 0 and earned -68.65M in profits. Earnings per share was -1.06.

Revenue
0
Gross Profit
0
Operating Income
-75.25M
Pretax Income
-68.65M
Net Income
-68.65M
EBITDA
-68.60M
Earnings Per Share (EPS)
-1.06

Cash Flow

In the last 12 months, operating cash flow was -81.60M and capital expenditures -90,000, giving a free cash flow of -81.69M billion.

Operating Cash Flow
-81.60M
Free Cash Flow
-81.69M
Free Cash Flow per Share
-0.64

Dividends & Yields

Zura Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-68.39%
Earnings Yield
-59.06%

Stock Price Statistics

Beta
0.91
52-Week Price Change
-71.86%
50-Day Moving Average
3.74
200-Day Moving Average
4.38
Relative Strength Index (RSI)
27.28
Average Volume (3m)
810

Important Dates

Zura Bio upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 27, 2026
Next Earnings Date
Mar 31, 2027
Ex-Dividend Date
―

Financial Position

Zura Bio as a current ratio of 9.05, with Debt / Equity ratio of 0.00%

Current Ratio
9.05
Quick Ratio
9.05
Debt to Market Cap
0.00
Net Debt to EBITDA
1.59
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Zura Bio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Zura Bio EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 0.83.

EV to Sales
0.00
EV to EBITDA
0.72
EV to Free Cash Flow
0.83
EV to Operating Cash Flow
0.84

Balance Sheet

Zura Bio has EUR 187.65M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 187.65M billion.

Cash & Marketable Securities
EUR 187.65M
Total Debt
EUR 0.00
Net Cash
EUR 187.65M
Net Cash Per Share
EUR 1.95
Tangible Book Value Per Share
EUR 1.39

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Zura Bio is EUR 9.68, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 9.68
Price Target Upside
763.95% Upside
Analyst Consensus
Strong Buy
Analyst Count
6
Revenue Growth Forecast
―
EPS Growth Forecast
-68.00%

Scores

Smart Score
2
AI Score
―